HUP9800859A1 - 6,7,8,9-Tetrahidro-ciklopenta[a]naftalin és 2,3-dihidro-ciklopenta[e]indén aminszármazékai, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények - Google Patents
6,7,8,9-Tetrahidro-ciklopenta[a]naftalin és 2,3-dihidro-ciklopenta[e]indén aminszármazékai, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP9800859A1 HUP9800859A1 HU9800859A HUP9800859A HUP9800859A1 HU P9800859 A1 HUP9800859 A1 HU P9800859A1 HU 9800859 A HU9800859 A HU 9800859A HU P9800859 A HUP9800859 A HU P9800859A HU P9800859 A1 HUP9800859 A1 HU P9800859A1
- Authority
- HU
- Hungary
- Prior art keywords
- cyclopenta
- hydrogen atom
- carbon atoms
- general formula
- powder
- Prior art date
Links
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 title 2
- CGQXGMYECNOURB-UHFFFAOYSA-N 2,3-dihydro-as-indacene Chemical compound C1=C2C=CC=C2C2=CCCC2=C1 CGQXGMYECNOURB-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 239000000843 powder Substances 0.000 abstract 5
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- ATRQECRSCHYSNP-UHFFFAOYSA-N 2-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=CC=N1 ATRQECRSCHYSNP-UHFFFAOYSA-N 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- JVZRCNQLWOELDU-UHFFFAOYSA-N gamma-Phenylpyridine Natural products C1=CC=CC=C1C1=CC=NC=C1 JVZRCNQLWOELDU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052683 pyrite Inorganic materials 0.000 abstract 1
- 239000011028 pyrite Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000011117 substance-related disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/50—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Az (I) általánős képletű új aminőszármazékők -, a képletben n jelentése 0 vagy 1, és Y jelentése hidrőgénatőm vagy (a), (b) vagy (c) általánős képletűcsőpőrt, amelyekben W jelentése hidrőgénatőm vagy 1-5 szénatőmős alkil-, alkenil- vagyalkinilcsőpőrt, p jelentése 1 és 5 közötti egész szám, R1 és R2 jelentése azőnősan vagy eltérően hidrőgénatőm, halőgénatőm,hidrőxilcsőpőrt, 1-5 szénatőmős alkőxicsőpőrt, -NH-SO2-CH3, -NH-SO2-CF3, -NH-CO-CH3, -NH-CO-CF3 képletű csőpőrt vagy (d) általánős képletűcsőpőrt, amelyben R4 és R5 jelentése azőnősan vagy eltérőenhidrőgénatőm vagy 1-6 szénatőmős alkilcsőpőrt, m értéke 2 és 5 közötti egész szám, és R3 jelentése hidrőgénatőm, halőgénatőm, hidrőxilcsőpőrt,alkőxicsőpőrt, triflűőr-metil-csőpőrt, cianőcsőpőrt vagy fenilcsőpőrt- racém főrmában vagy őptikai izőmerek főrmájában, valamint a fentivegyületek gyógyászatilag elfőgadható savakkal alkőtőtt savaddícióssói D3 receptőrhőz való szelektív kötődésük miattgyógyszerkészítmények hatóanyagaként Parkinsőn-kór, memória-rendellenességek, drőgfüggőséggel kapcsőlatős rendellenességek,depresszió, skizőfrénia és pszichózisők kezelésére alkalmazhatók. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9704421A FR2761985B1 (fr) | 1997-04-10 | 1997-04-10 | Nouveaux composes amines du 6,7,8,9-tetrahydro-cyclopenta[a] naphtalene et du 2,3-dihydro-cyclopenta[e]indene, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9800859D0 HU9800859D0 (en) | 1998-05-28 |
HUP9800859A1 true HUP9800859A1 (hu) | 1999-12-28 |
Family
ID=9505753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9800859A HUP9800859A1 (hu) | 1997-04-10 | 1998-04-09 | 6,7,8,9-Tetrahidro-ciklopenta[a]naftalin és 2,3-dihidro-ciklopenta[e]indén aminszármazékai, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények |
Country Status (19)
Country | Link |
---|---|
US (1) | US5945566A (hu) |
EP (1) | EP0870759B1 (hu) |
JP (1) | JPH10287631A (hu) |
CN (1) | CN1207384A (hu) |
AT (1) | ATE199897T1 (hu) |
AU (1) | AU739049B2 (hu) |
BR (1) | BR9801386A (hu) |
CA (1) | CA2235053C (hu) |
DE (1) | DE69800604T2 (hu) |
DK (1) | DK0870759T3 (hu) |
ES (1) | ES2157644T3 (hu) |
FR (1) | FR2761985B1 (hu) |
GR (1) | GR3035644T3 (hu) |
HU (1) | HUP9800859A1 (hu) |
NO (1) | NO981566L (hu) |
NZ (1) | NZ330169A (hu) |
PL (1) | PL325749A1 (hu) |
PT (1) | PT870759E (hu) |
ZA (1) | ZA983045B (hu) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2761985B1 (fr) * | 1997-04-10 | 1999-05-21 | Adir | Nouveaux composes amines du 6,7,8,9-tetrahydro-cyclopenta[a] naphtalene et du 2,3-dihydro-cyclopenta[e]indene, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
AR023681A1 (es) | 1998-10-08 | 2002-09-04 | Smithkline Beecham Plc | Derivados de tetrahidrobenzazepinas, composiciones farmaceuticas y el uso de los mismos para la manufactura de un medicamento. |
US6276093B1 (en) * | 1999-11-15 | 2001-08-21 | Lawrence M. Janesky | Air-tight sump cover with water inlet |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6045179B2 (ja) * | 1977-06-08 | 1985-10-08 | フナイ薬品工業株式会社 | 新規環状アミノアルコ−ル類およびその製造法 |
FR2761985B1 (fr) * | 1997-04-10 | 1999-05-21 | Adir | Nouveaux composes amines du 6,7,8,9-tetrahydro-cyclopenta[a] naphtalene et du 2,3-dihydro-cyclopenta[e]indene, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1997
- 1997-04-10 FR FR9704421A patent/FR2761985B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-06 EP EP98400811A patent/EP0870759B1/fr not_active Expired - Lifetime
- 1998-04-06 AT AT98400811T patent/ATE199897T1/de not_active IP Right Cessation
- 1998-04-06 DE DE69800604T patent/DE69800604T2/de not_active Expired - Fee Related
- 1998-04-06 DK DK98400811T patent/DK0870759T3/da active
- 1998-04-06 ES ES98400811T patent/ES2157644T3/es not_active Expired - Lifetime
- 1998-04-06 NO NO981566A patent/NO981566L/no not_active Application Discontinuation
- 1998-04-06 PT PT98400811T patent/PT870759E/pt unknown
- 1998-04-08 BR BR9801386A patent/BR9801386A/pt not_active IP Right Cessation
- 1998-04-08 CA CA002235053A patent/CA2235053C/fr not_active Expired - Fee Related
- 1998-04-08 PL PL98325749A patent/PL325749A1/xx unknown
- 1998-04-09 AU AU60765/98A patent/AU739049B2/en not_active Ceased
- 1998-04-09 CN CN98108880A patent/CN1207384A/zh active Pending
- 1998-04-09 JP JP10097429A patent/JPH10287631A/ja active Pending
- 1998-04-09 US US09/166,951 patent/US5945566A/en not_active Expired - Fee Related
- 1998-04-09 ZA ZA983045A patent/ZA983045B/xx unknown
- 1998-04-09 NZ NZ330169A patent/NZ330169A/xx unknown
- 1998-04-09 HU HU9800859A patent/HUP9800859A1/hu unknown
-
2001
- 2001-03-28 GR GR20010400497T patent/GR3035644T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2235053A1 (fr) | 1998-10-10 |
CN1207384A (zh) | 1999-02-10 |
NO981566D0 (no) | 1998-04-06 |
EP0870759A1 (fr) | 1998-10-14 |
AU6076598A (en) | 1998-10-15 |
FR2761985A1 (fr) | 1998-10-16 |
NZ330169A (en) | 1998-10-28 |
PT870759E (pt) | 2001-06-29 |
DE69800604T2 (de) | 2001-09-27 |
HU9800859D0 (en) | 1998-05-28 |
EP0870759B1 (fr) | 2001-03-21 |
PL325749A1 (en) | 1998-10-12 |
FR2761985B1 (fr) | 1999-05-21 |
BR9801386A (pt) | 1999-05-18 |
ATE199897T1 (de) | 2001-04-15 |
AU739049B2 (en) | 2001-10-04 |
GR3035644T3 (en) | 2001-06-29 |
ZA983045B (en) | 1998-10-20 |
ES2157644T3 (es) | 2001-08-16 |
DE69800604D1 (de) | 2001-04-26 |
US5945566A (en) | 1999-08-31 |
NO981566L (no) | 1998-10-12 |
CA2235053C (fr) | 2002-06-18 |
JPH10287631A (ja) | 1998-10-27 |
DK0870759T3 (da) | 2001-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ514487A (en) | Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands | |
HUP9802814A2 (hu) | Szelektív béta3 adrenergiás agonista hatású vegyületek, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
ES8308309A1 (es) | Procedimiento para la preparacion de derivados de benzazepina. | |
ATE185807T1 (de) | Thiazolylbenzofuranderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
CA2107014A1 (en) | Therapeutic Agent for Parkinson's Disease | |
MY128659A (en) | Novel aminodicarboxylic acid derivatives having pharmaceutical properties | |
MY127718A (en) | Dolastatin 10 derivatives. | |
HUP0203184A2 (hu) | Izoxazolkarboxamid-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
NZ522195A (en) | Novel amino carboxy alkyl derivatives of barbituric acid, preparation process and use for treating central nervous system disorders thereof | |
KR890001957A (ko) | N-아미노부틸-n-페닐아릴아미드 유도체, 그의 제법 및 치료에의 응용 | |
ATE59632T1 (de) | Dihydrodibenzocycloheptylidenethylamin-derivate | |
HUP0003624A2 (hu) | 1,2,3,4-Tetrahidro-benzofuro[3,2-c]piridin-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
HUP9800859A1 (hu) | 6,7,8,9-Tetrahidro-ciklopenta[a]naftalin és 2,3-dihidro-ciklopenta[e]indén aminszármazékai, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények | |
ES8303398A1 (es) | Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida. | |
IL115184A0 (en) | Anthracycline derivatives their preparation and use | |
KR910004598A (ko) | 2,3-디하이드로-1-(피리디닐아미노)-인돌, 이의 제조방법 및 약제로서 이의 용도 | |
PT75567B (fr) | Procede de preparation de derives d'amino-2 tetrahydro-1,2,3,4 naphtalene et de compositions pharmaceutiques les contenant | |
HUP9601331A2 (hu) | Piperazin- illetve homopiperazinszármazékok, eljárás előállításukra, és ilyen hatóanyagot tartalmazó gyógyászati készítmények | |
NZ510116A (en) | Tricyclic delta-3-piperidines as pharmaceuticals | |
DE3480839D1 (de) | Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung. | |
TR200002831A2 (tr) | Kinolin-4-İl türevleri I | |
EP0228314A3 (en) | Use of ethanol/amine derivatives in treating or preventing hyperlipemia | |
IL70757A (en) | 3-morpholinoethylamino-6-cyclohexyl-or-thienylpyridazine derivatives,their preparation and pharmaceutical compositions containing them | |
ES8602712A1 (es) | Un procedimiento para preparar un derivado de rodanina | |
SE9601708D0 (sv) | Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders |